Related Experiment Videos
Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum
Cancer Detection and Prevention
|January 1, 1987
Summary
A novel P factor from human plasma effectively differentiates tumor from normal tissue when used to absorb anti-carcinoembryonic antigen (CEA) serum, unlike NCA. This improves immunocytochemistry for colorectal cancer detection.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Carcinoembryonic antigen (CEA) is a tumor marker often used in diagnostics.
- Nonspecific cross-reacting antigen (NCA) can interfere with CEA-specific antibody assays.
- Distinguishing between CEA and cross-reacting antigens is crucial for accurate immunocytochemistry.
Purpose of the Study:
- To isolate and characterize a plasma factor (P factor) that cross-reacts with CEA.
- To compare the efficacy of P factor and NCA in absorbing anti-CEA serum for immunocytochemistry.
- To determine the utility of P factor for specific detection of colorectal adenocarcinoma.
Main Methods:
- Isolation of P factor from normal human plasma.
- Absorption of anti-CEA serum with both P factor and NCA.
- Immunohistochemical staining using beta-galactosidase on colonic adenocarcinoma and normal colonic mucosa sections.
Main Results:
- Unabsorbed antiserum stained both normal and cancerous colon tissues.
- Absorption with NCA resulted in paler staining but retained signal in normal mucosa and granulocytes.
- Absorption with P factor completely abolished staining in normal colonic mucosa, highlighting tumor structures.
Conclusions:
- Nonspecific cross-reacting antigen (NCA) is unsuitable for absorbing anti-CEA serum in immunocytochemistry.
- The isolated P factor from plasma is effective for absorbing anti-CEA serum, enabling specific tumor visualization.
- P factor offers improved results for immunocytochemical techniques targeting colorectal adenocarcinoma.